Showing results (91-100 of 115) with videos related to
Sort By:
Pageof 12
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|July 26, 2024
Effects of the Beijing genotype on latent tuberculosis infection, TB disease risk, and clustering of TB casesMichael Asare-Baah, Marie Nancy Séraphin, LaTweika A T Salmon-Trejo, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2009
Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosisCatherine Boulanger, Elena Hollender, Karen Farrell, et al.Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|December 3, 2019
Tuberculosis Regional Training and Medical Consultation Centers in the United States: Characteristics, outcomes, and quality of medical consultations, June 1, 2010 - May 31, 2014Sundari R Mase, Ratima Samron, David Ashkin, et al.Emerging Infectious Diseases|November 23, 2020
Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United StatesConnie A Haley, Patricia Macias, Supriya Jasuja, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 28, 2023
Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitusY Alkabab, J Warkentin, J Cummins, et al.Antimicrobial Agents and Chemotherapy|August 12, 2020
Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment AnalysisWael A Alghamdi, Mohammad H Al-Shaer, Guohua An, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 8, 2004
Pharmacokinetics of ethambutol in children and adults with tuberculosisM Zhu, W J Burman, J R Starke, et al.Antimicrobial Agents and Chemotherapy|July 8, 2020
Ethionamide Population Pharmacokinetic Model and Target Attainment in Multidrug-Resistant TuberculosisMohammad H Al-Shaer, Anne-Grete Märtson, Wael A Alghamdi, et al.Science Translational Medicine|January 18, 2019
Tuberculosis following PD-1 blockade for cancer immunotherapyDaniel L Barber, Shunsuke Sakai, Ragini R Kudchadkar, et al.Journal of Substance Abuse Treatment|February 15, 2021
The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jailBenjamin A Howell, Lisa Puglisi, Katie Clark, et al.Pageof 12